Patents/Assignees

Horizon Therapeutics USA, Inc.

8 patents in portfolio

US12496331utility2025
Combination Therapies of Prednisone and Uricase Molecules and Uses Thereof
0 cites
US12465631utility2025
Reducing Immunogenicity to Pegloticase
0 cites
US12188927utility2025
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
0 cites
US12121566utility2024
Methods for Treating Gout
0 cites
US11982670utility2024
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
0 cites
US11781119utility2023
Variant Forms of Urate Oxidase and Use Thereof
0 cites
US11639927utility2023
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
0 cites
US11598767utility2023
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
0 cites